453 related articles for article (PubMed ID: 17197361)
1. Mitotically active leiomyoma of the uterus in a postmenopausal breast cancer patient receiving tamoxifen.
Liu IF; Yen YS; Cheng YM; Chou CY
Taiwan J Obstet Gynecol; 2006 Jun; 45(2):167-9. PubMed ID: 17197361
[TBL] [Abstract][Full Text] [Related]
2. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen-induced growth of leiomyomas. A case report.
Kang J; Baxi L; Heller D
J Reprod Med; 1996 Feb; 41(2):119-20. PubMed ID: 8656411
[TBL] [Abstract][Full Text] [Related]
4. MR imaging appearance of the uterus in postmenopausal women receiving tamoxifen therapy for breast cancer: histopathologic correlation.
Ascher SM; Johnson JC; Barnes WA; Bae CJ; Patt RH; Zeman RK
Radiology; 1996 Jul; 200(1):105-10. PubMed ID: 8657895
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen-associated post-menopausal endometriosis.
Ismail SM; Maulik TG
Histopathology; 1997 Feb; 30(2):187-91. PubMed ID: 9067744
[No Abstract] [Full Text] [Related]
6. Uterine leiomyomata and endometrial proliferation in postmenopausal women treated with the anti-oestrogen tamoxifen.
Ugwumadu AH; Harding K
Eur J Obstet Gynecol Reprod Biol; 1994 Apr; 54(2):153-6. PubMed ID: 8070603
[TBL] [Abstract][Full Text] [Related]
7. Concurrent tamoxifen-related Müllerian adenofibromas in uterus and ovary.
Shi H; Chen X; Lv B; Zhang X
Int J Clin Exp Pathol; 2015; 8(11):15381-5. PubMed ID: 26823898
[TBL] [Abstract][Full Text] [Related]
8. [Expansive uterine myoma during tamoxifen therapy. 11 cases].
Le Bouëdec G; de Latour M; Dauplat J
Presse Med; 1995 Nov; 24(36):1694-6. PubMed ID: 8545398
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.
McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF
Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294
[TBL] [Abstract][Full Text] [Related]
10. High-grade endometrial stromal sarcoma after tamoxifen therapy for breast cancer.
Sesti F; Patrizi L; Ermini B; Palmieri G; Orlandi A; Piccione E
Gynecol Obstet Invest; 2005; 60(2):117-20. PubMed ID: 15920338
[TBL] [Abstract][Full Text] [Related]
11. Aromatase inhibitors and postmenopausal breast cancer patients with tamoxifen-induced endometrial pathology.
Morales L; Paridaens R; Timmerman D; Neven P
Clin Cancer Res; 2006 Sep; 12(18):5603. PubMed ID: 17000698
[No Abstract] [Full Text] [Related]
12. High frequency of adenomyosis in postmenopausal breast cancer patients treated with tamoxifen.
Cohen I; Beyth Y; Shapira J; Tepper R; Fishman A; Cordoba M; Bernheim J; Yigael D; Altaras MM
Gynecol Obstet Invest; 1997; 44(3):200-5. PubMed ID: 9359649
[TBL] [Abstract][Full Text] [Related]
13. [Comparative study of the endometrial pathology using flexible ambulatory hysteroscopy of patients treated with Tamoxifen].
Kuzmanov B
Akush Ginekol (Sofiia); 2004; 43(3):32-3. PubMed ID: 15341254
[TBL] [Abstract][Full Text] [Related]
14. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
Hauth E; Libera H; Kimmig R; Forsting M
Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
[TBL] [Abstract][Full Text] [Related]
15. Adenomyosis in the broad ligament and tamoxifen: report of a case.
Chung YP; Lin HH; Sheu BC; Mao TL; Chang DY; Huang SC
J Obstet Gynaecol Res; 1997 Feb; 23(1):69-73. PubMed ID: 9094821
[TBL] [Abstract][Full Text] [Related]
16. Carcinoid tumor of the uterine corpus. A case report.
González-Bosquet E; González-Bosquet J; García Jiménez A; Gil A; Xercavins J
J Reprod Med; 1998 Sep; 43(9):844-6. PubMed ID: 9777628
[TBL] [Abstract][Full Text] [Related]
17. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W
Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080
[TBL] [Abstract][Full Text] [Related]
18. Carcinosarcoma arising in uterine didelphys after tamoxifen therapy for breast cancer: a case report.
Suprasert P; Khunamornpong S
J Med Assoc Thai; 2010 May; 93(5):608-12. PubMed ID: 20524448
[TBL] [Abstract][Full Text] [Related]
19. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.
Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S
Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913
[TBL] [Abstract][Full Text] [Related]
20. Leiomyoma of the breast in a 50-year-old woman receiving tamoxifen.
Son EJ; Oh KK; Kim EK; Son HJ; Jung WH; Lee HD
AJR Am J Roentgenol; 1998 Dec; 171(6):1684-6. PubMed ID: 9843313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
